Change of Address

ABREVA

GlaxoSmithKline Consumer Healthcare (UK) IP Limited

Request for Extension of Time to File a Statement of Use

Change Of Correspondence Address

The table below presents the data as entered.

Input Field	Entered
SERIAL NUMBER	86790349
LAW OFFICE ASSIGNED	LAW OFFICE 109
MARK SECTION
MARK	ABREVA (see, http://tmng-al.gov.uspto.report/resting2/api/img/86790349/large)
NEW CORRESPONDENCE ADDRESS
NEW ADDRESS	TERENCE A. DIXON Gsk 5 Crescent Dr Philadelphia Pennsylvania United States 19112-1001 trademarks@gsk.com
AUTHORIZED TO COMMUNICATE VIA E-MAIL	YES
INDIVIDUAL ATTORNEY DOCKET/REFERENCE NUMBER	81239144
FILING INFORMATION SECTION
SUBMIT DATE	Tue Sep 13 13:44:06 EDT 2016
TEAS STAMP	USPTO/ESU-XXX.XX.XX.X-201 60913134406176318-8679034 9-5503593c72987166fc6b083 a3fa1ac96fdc3f5788aa9b2bf 3357676d2a36871a336-DA-11 450-20160906080010852822

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.